Rhelixa

Decoding Life, Creating Future.

Tokyo, Japan · Founded 2015

Headquarters
Tokyo
Employees
11–50
Founded
2015
Business Model
B2B
Last Round
Series BAug 2024
Rounds
2

About

Rhelixa is a Tokyo-based biotechnology company and leading provider of epigenomic analysis services, applying proprietary technologies to analyze genomic, epigenomic, transcriptomic, and metagenomic data for life science research and development. Founded in 2015, the company partners with pharmaceutical, food, and healthcare companies to dramatically improve the efficiency and accuracy of R&D through scientific consulting and bioinformatics services. Its tagline reflects its mission to decode biological information to advance personalized health, drug development, and longevity research.

Summary

Rhelixa is a Biotech company based in Tokyo, Japan, founded in 2015. Its most recent funding was a Series B round in Aug 2024. Investors include Global Brain and Kirin Health Innovation Fund.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BAug 2024

Sign up to see all 2 rounds

Venture Round through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Rhelixa on Indexed.vc
<a href="https://indexed.vc/companies/rhelixa"><img src="https://indexed.vc/api/badge/company/rhelixa" alt="Rhelixa on Indexed.vc" width="260" height="76" /></a>